This site is intended for healthcare professionals
News

Remitoro, intravenous drip infusion is approved in Japan for peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Eisai .

Read time: 1 mins
Last updated:24th Mar 2021
Published:24th Mar 2021
Condition: T- cell Lymphoma
Type: drug
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest